China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2011-11-30 01:30 Sihuan Bioengineering Sues Vitapharm to Unwind Deal 2011-11-29 01:30 Regeneron/Bayer Start China Trial of Wet AMD Drug and more... 2011-11-27 01:30 The Week in Review: Huge China Hi-Tech Stimulus Rumored 2011-11-26 01:30 Fosun Pharma to Float up to $470 Million in Bonds and more... 2011-11-24 01:30 A Second Life for Bayer's Diabetes Drug in China 2011-11-23 01:30 Lilly Concerned about IP Protection in China 2011-11-22 01:30 China Plans $1.7 Trillion Investment in Hi-Tech, including Biotechnology and more... 2011-11-20 01:30 The Week in Review: ASLAN Pharma - Leveraging Asia Pacific's CROs 2011-11-19 01:30 BGI Forms Children's Disease Partnership with Philadelphia Hospital 2011-11-18 01:30 ASLAN Pharma - A Very Focused Business Plan and more... 2011-11-17 01:30 Italian Pharma Menarini Buys Invida of Singapore and more... 2011-11-16 01:30 Pfizer's Shanghai Anti-Infectives Research Unit Delayed and more... 2011-11-15 01:30 Hutchison MediPharma Starts Clinical Trial of Cancer Drug 2011-11-13 01:30 The Week in Review: CNBG Schedules $2 Billion IPO in Hong Kong 2011-11-12 01:30 WuXi PharmaTech to Form $50 Million Venture Fund and more... 2011-11-11 01:30 China Resources Medications Forms $158 Million JV with Pientzehuang 2011-11-10 01:30 Former Head of Shanghai Pharma Given Death Sentence for Accepting Bribes and more... 2011-11-09 01:30 China Biotech's Hong Kong IPO to Raise Up to $2 Billion and more... 2011-11-08 01:30 Sanofi Says China Sales Grew 47% to $370 Million in Q3 2011-11-06 01:30 The Week in Review: Roche's China Strategy 2011-11-05 01:30 China National Biotechnology to IPO on the Hong Kong Exchange and more... 2011-11-04 01:30 Aslan Pharma In-licenses China Rights to BMS Cancer Drug 2011-11-03 01:30 Novo Nordisk Rejects China M&A; Will Grow through Innovation and more... 2011-11-02 01:30 Healthgen, a China Startup, Announces Rice-Derived Human Serum Albumin 2011-11-01 01:30 Alios Signs Flu Treatment Deal with Univ. of Hong Kong   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC